Literature DB >> 10433072

p56lck activity and expression in peripheral blood lymphocytes from patients with systemic lupus erythematosus.

C Matache1, M Stefanescu, A Onu, S Tanaseanu, I Matei, R Frade, G Szegli.   

Abstract

In this study we analyzed the activity and the expression of p56lck protein tyrosine kinase in peripheral blood lymphocytes (PBLs) from systemic lupus erythematosus (SLE) patients and from healthy donors. The p56lck activity, determined by a non-radioactive Tyrosine Kinase Assay Kit, was significantly higher in active SLE PBLs and discriminated this group of patients from inactive SLE patients (p = 0.002) and healthy donors (p = 0.009). p56lck level decreased in SLE lymphocytes (especially for inactive SLE lymphocytes, p = 0.005) when compared to healthy donors. These differences were also reflected by the specific activity of p56lck that was clearly elevated in active SLE lymphocytes when compared to inactive SLE (p = 0.022) or healthy donors lymphocytes (p = 0.006). A positive correlation between the activity of p56lck and the tyrosine phosphorylation level in active SLE lymphocytes was found.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10433072     DOI: 10.3109/08916939908995380

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  8 in total

1.  Altered regulation of IL-2 production in systemic lupus erythematosus: an evolving paradigm.

Authors:  Gary M Kammer
Journal:  J Clin Invest       Date:  2005-04       Impact factor: 14.808

Review 2.  T-lymphocyte signalling in systemic lupus erythematosus: a lipid raft perspective.

Authors:  E C Jury; P S Kabouridis
Journal:  Lupus       Date:  2004       Impact factor: 2.911

3.  Association between the expression of IL-10 and T cell activation proteins loss in early breast cancer patients.

Authors:  Leticia Llanes-Fernández; Maria del Carmen Arango-Prado; Juan Manuel Alcocer-González; Marta Elena Guerra-Yi; Sonia Franco-Odio; Rolando Camacho-Rodríguez; Vicente Madrid-Marina; Reyes Tamez-Guerra; Cristina Rodríguez-Padilla
Journal:  J Cancer Res Clin Oncol       Date:  2008-07-24       Impact factor: 4.553

Review 4.  The role of nitric oxide in abnormal T cell signal transduction in systemic lupus erythematosus.

Authors:  Gyorgy Nagy; Andras Perl
Journal:  Clin Immunol       Date:  2006-01-10       Impact factor: 3.969

Review 5.  The pathology of T cells in systemic lupus erythematosus.

Authors:  Anselm Mak; Nien Yee Kow
Journal:  J Immunol Res       Date:  2014-04-23       Impact factor: 4.818

Review 6.  MAP4K Family Kinases and DUSP Family Phosphatases in T-Cell Signaling and Systemic Lupus Erythematosus.

Authors:  Huai-Chia Chuang; Tse-Hua Tan
Journal:  Cells       Date:  2019-11-13       Impact factor: 6.600

7.  Roles of CD147 on T lymphocytes activation and MMP-9 secretion in systemic lupus erythematosus.

Authors:  Gina Pistol; Cristiana Matache; Ana Calugaru; Crina Stavaru; Stefanita Tanaseanu; Ruxandra Ionescu; Sergiu Dumitrache; Maria Stefanescu
Journal:  J Cell Mol Med       Date:  2007 Mar-Apr       Impact factor: 5.310

Review 8.  Aberrant T Cell Signaling and Subsets in Systemic Lupus Erythematosus.

Authors:  Takayuki Katsuyama; George C Tsokos; Vaishali R Moulton
Journal:  Front Immunol       Date:  2018-05-17       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.